AngioCare Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 23

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

AngioCare General Information

Description

Distributor of diagnostic and interventional therapeutic products for cardiology, radiology, vascular surgery and oncology. The company offers diagnostic catheters, lead adaptors, guide catheter extensions, liquid embolic, drug-eluting balloons and introducer sheaths.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Spacelab 3
  • 3824 MR Amersfoort
  • Netherlands
+31 035
Primary Industry
Distributors (Healthcare)
Other Industries
Other Devices and Supplies
Parent Company
Uniphar Group
Vertical(s)
Corporate Office
  • Spacelab 3
  • 3824 MR Amersfoort
  • Netherlands
+31 035

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AngioCare Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AngioCare‘s full profile, request access.

Request a free trial

AngioCare Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Distributor of diagnostic and interventional therapeutic products for cardiology, radiology, vascular surgery and oncolo
Distributors (Healthcare)
Amersfoort, Netherlands
23 As of 2023

Oxford, United Kingdom
 

Tucson, AZ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AngioCare Competitors (2)

One of AngioCare’s 2 competitors is Cerus Endovascular, a Formerly VC-backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cerus Endovascular Formerly VC-backed Oxford, United Kingdom
Accelerate Diagnostics Corporation Tucson, AZ
You’re viewing 2 of 2 competitors. Get the full list »

AngioCare Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AngioCare Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AngioCare‘s full profile, request access.

Request a free trial

AngioCare FAQs

  • When was AngioCare founded?

    AngioCare was founded in 2003.

  • Where is AngioCare headquartered?

    AngioCare is headquartered in Amersfoort, Netherlands.

  • What is the size of AngioCare?

    AngioCare has 23 total employees.

  • What industry is AngioCare in?

    AngioCare’s primary industry is Distributors (Healthcare).

  • Is AngioCare a private or public company?

    AngioCare is a Private company.

  • What is AngioCare’s current revenue?

    The current revenue for AngioCare is .

  • Who are AngioCare’s investors?

    Angiodynamics has invested in AngioCare.

  • Who are AngioCare’s competitors?

    Cerus Endovascular and Accelerate Diagnostics are competitors of AngioCare.

  • When was AngioCare acquired?

    AngioCare was acquired on 08-Oct-2018.

  • Who acquired AngioCare?

    AngioCare was acquired by Uniphar Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »